BioAtla, Inc. SEC filings BCAB
BioAtla, Inc. has 509 filings in SEC EDGAR's recent list, going back to Oct 6, 2020. Its latest annual report, Form ARS, was filed on Jun 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 20, 2026 (material agreement, agreement ended, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Oct 29, 2026 | — |
| S-1 | Registration statement | Oct 20, 2026 | — |
| S-8 | Employee stock plan registration | Mar 31, 2026 | — |
| 424B2 | Prospectus | Mar 20, 2026 | — |
| 424B2 | Prospectus | Mar 13, 2026 | — |
| 424B2 | Prospectus | Mar 9, 2026 | — |
| S-3 | Shelf registration | Jan 16, 2026 | — |
| 424B5 | Prospectus supplement | Nov 21, 2025 | — |
| 424B3 | Prospectus | May 16, 2025 | — |
| S-3 | Shelf registration | May 6, 2025 | — |
| S-8 | Employee stock plan registration | Mar 28, 2025 | — |
| 424B5 | Prospectus supplement | Dec 20, 2024 | — |
| S-8 | Employee stock plan registration | Mar 26, 2024 | — |
| S-8 | Employee stock plan registration | Mar 23, 2023 | — |
| S-3 | Shelf registration | Jan 6, 2023 | — |
| 424B5 | Prospectus supplement | Jan 6, 2023 | — |
| 424B5 | Prospectus supplement | Nov 7, 2022 | — |
| POS AM | Filing | May 17, 2022 | — |
| 424B3 | Prospectus | Mar 1, 2022 | — |
| S-8 | Employee stock plan registration | Mar 1, 2022 | — |
| POS AM | Filing | Mar 1, 2022 | — |
| S-3ASR | Automatic shelf registration | Feb 4, 2022 | — |
| 424B3 | Prospectus | Nov 3, 2021 | — |
| S-1 | Registration statement | Oct 22, 2021 | — |
| S-8 | Employee stock plan registration | Mar 24, 2021 | — |
| S-8 | Employee stock plan registration | Dec 18, 2020 | — |
| 424B4 | Prospectus | Dec 17, 2020 | — |
| S-1MEF | Filing | Dec 15, 2020 | — |
| S-1/A | Amended registration statement | Dec 9, 2020 | — |
| S-1/A | Amended registration statement | Dec 8, 2020 | — |
| S-1 | Registration statement | Nov 13, 2020 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BCAB (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1826892
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.